KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $220,000 | -9.8% | 64,782 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $244,000 | -7.9% | 64,782 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $265,000 | -12.0% | 64,782 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $301,000 | -34.6% | 64,782 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $460,000 | -1.7% | 64,782 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $468,000 | +17.3% | 64,782 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $399,000 | +5.0% | 64,782 | 0.0% | 0.00% | 0.0% |
Q4 2016 | $380,000 | +10.5% | 64,782 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $344,000 | -19.8% | 64,782 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $429,000 | +41.6% | 64,782 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $303,000 | -7.3% | 64,782 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $327,000 | +43.4% | 64,782 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $228,000 | -64.6% | 64,782 | +0.4% | 0.00% | -50.0% |
Q2 2015 | $644,000 | -21.6% | 64,502 | 0.0% | 0.00% | -33.3% |
Q1 2015 | $821,000 | -8.4% | 64,502 | +1.9% | 0.00% | 0.0% |
Q4 2014 | $896,000 | +2.9% | 63,327 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $871,000 | -10.6% | 63,327 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $974,000 | +2.1% | 63,327 | +13.2% | 0.00% | 0.0% |
Q1 2014 | $954,000 | +31.6% | 55,958 | 0.0% | 0.00% | +50.0% |
Q4 2013 | $725,000 | +28.3% | 55,958 | 0.0% | 0.00% | 0.0% |
Q3 2013 | $565,000 | +35.2% | 55,958 | 0.0% | 0.00% | +100.0% |
Q2 2013 | $418,000 | – | 55,958 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 700,273 | $10,770,000 | 5.76% |
HARVEY CAPITAL MANAGEMENT INC | 932,400 | $14,340,000 | 5.13% |
Camber Capital Management LP | 3,000,000 | $46,140,000 | 3.02% |
Baupost Group | 10,539,986 | $162,105,000 | 2.64% |
SECTORAL ASSET MANAGEMENT INC | 3,741,656 | $57,547,000 | 2.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,884,409 | $59,742,000 | 2.40% |
Knoll Capital Management, LLC | 200,000 | $3,076,000 | 1.37% |
DAFNA Capital Management LLC | 92,400 | $1,421,000 | 1.35% |
NORTHPOINTE CAPITAL LLC | 892,011 | $13,719,000 | 1.32% |
Rhenman & Partners Asset Management AB | 240,000 | $3,691,000 | 1.10% |